Sumita Ray was Promoted as General Counsel at Calithera

Date of management change: October 03, 2017 

What Happened?

South San Francisco, -based Calithera Promoted Sumita Ray as General Counsel

 

About the Company

Calithera is discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Tumor metabolism and tumor immunology have emerged as promising new fields for cancer drug discovery, and recent clinical successes with therapeutic agents in each field have demonstrated the potential to create fundamentally new therapies for cancer patients. Our lead product candidate in tumor metabolism, CB-839, is an internally discovered, first-in-class inhibitor of glutaminase, a critical enzyme in tumor metabolism. We are currently evaluating CB-839 in three Phase 1 clinical trials in solid and hematological tumors. In tumor immunology, our lead preclinical program is directed at developing inhibitors of the enzyme arginase and may provide a first-in-class therapeutic agent for this novel target. Our ongoing research efforts are focused on discovering additional product candidates against novel tumor metabolism and immunology targets.

 

About the Person

Sumita Ray is Chief Legal, Compliance and Administrative Officer and Corporate Secretary at Instil Bio. Previously, Sumita held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Kellerman James, Ayazi Ali, Hennessee Marc, Perry Chad, Bade Joshua, Kushi Hisao, Hurd Phillip, Smallman Tamara, Lassus Kenny, Jenkins David, Davidson Zoe

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.